Thanks to visit codestin.com
Credit goes to www.biomedcentral.com

Skip to main content
This website is moving to Springer Nature Link.

Call for papers - Cardiomyopathy and cardiac arrhythmias

Guest Editors

Muhammad Usman Almani, MD, Jefferson Einstein Hospital, USA
Giulio Francesco Romiti, MD, PhD, Sapienza University of Rome, Italy
Gaetano Santulli, MD, PhD, FAHA, Albert Einstein College of Medicine, USA

Submission Status: Open   |   Submission Deadline: 1 December 2025 

BMC Medicine is calling for submissions to our Collection on cardiomyopathies and cardiac arrhythmias. These include unknown etiology, lifestyle factors, and inherited cardiac conditions. Understanding the clinical characteristics, risk factors, and patterns of these cardiovascular diseases is essential to facilitate prevention, early diagnosis, and improve treatment strategies. 

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health and Well-being

Meet the Guest Editors

Back to top

Muhammad Usman Almani, MD, Jefferson Einstein Hospital, USA

Dr Almani is a dedicated cardiologist at Jefferson Einstein Hospital in Philadelphia, Pennsylvania. With extensive training in internal medicine and advanced heart failure, he specializes in the pathophysiology and management of complex cardiac conditions. Beyond clinical practice, Dr Almani is an accomplished researcher, contributing significantly to the field of cardiovascular medicine. His research focuses on cardiomyopathies, advanced heart failure, mechanical circulatory support, valvular heart disease, and cardiac arrhythmias.

Giulio Francesco Romiti, MD, PhD, Sapienza University of Rome, Italy

Dr Romiti is a medical doctor from Rome, Italy where he obtained his medical degree at Sapienza University of Rome. His research interests are related to cardiovascular field, with a particular focus on atrial fibrillation and its relationship with the concept of clinical complexity, as the detrimental interaction of different determinants of health. His other research interests are related to the study of integrated care approaches and their impact in improving prognosis in patients with complex health needs.

Gaetano Santulli, MD, PhD, FAHA, Albert Einstein College of Medicine, USA

Dr Santulli is a physician-scientist currently working as Associate Professor of Medicine (Cardiology) at Albert Einstein College of Medicine in New York, New York. Following his training at Columbia University Medical Center, his main current interests are focused on metabolic and cardiovascular disorders, including heart failure, arrhythmias, and diabetes.

About the Collection

BMC Medicine is calling for submissions to our Collection on cardiomyopathies and cardiac arrhythmias. These include unknown etiology, lifestyle factors, and inherited cardiac conditions. Understanding the clinical characteristics, risk factors, and patterns of these cardiovascular diseases is essential to facilitate prevention, early diagnosis, and improve treatment strategies.  

Advancing our collective understanding of cardiomyopathies, inherited conditions, and arrhythmias is vital for several reasons. First, it informs the development of novel therapies such as pulsed-field ablation and factor XI inhibition, which hint at safer, refined interventions. Furthermore, research highlights the importance of family screening and genetic counselling, which can help mitigate the risks associated with inherited cardiac conditions. Finally, increasing atrial fibrillation prevalence means it will become a public health challenge in future decades. Continued exploration in these fields promises to elucidate underlying mechanisms and ensure effective patient management that considers future healthcare resourcing.  

This Collection welcomes potential advances as research into cardiomyopathy and arrhythmias progresses. Future studies may lead to the identification of novel risk markers that predict cardiac conditions’ onset and progression. The integration of artificial intelligence and machine learning analyzing datasets to predict cardiovascular events could improve patient stratification through digital health methods. 

Clinical, epidemiological, meta-, –omics and translational research are amongst the methods welcomed research on the topics below: 

-Adult congenital heart disorders 

-Cardiac Imaging  

-Cardiomyopathy and genetic counseling 

-Cardiac electrophysiology (including surgical and catheter ablation) 

-Digital health wearables, remote monitoring, and AI tools 

-Inherited cardiac conditions 

-Implementation science and public health research 

-Lifestyle factors in cardiovascular diseases 

-Prescribing in comorbid/geriatric populations 

-Cardiac biology explaining arrhythmogenic/cardiomyopathic mechanisms 

-Sudden cardiac death/athlete screening 

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

This Collection supports and amplifies research related to SDG: 3 (Good Health and Well-being)

Image credit: © manassanant / Stock.adobe.com

  1. Low circulating transthyretin (TTR) concentration has been suggested as a biomarker of transthyretin tetramer instability, a prerequisite for the development of transthyretin cardiac amyloidosis. This study ai...

    Authors: Nan Zhang, Ziheng Jia, Jinhua Zhao, Xuyao Han, Jie Liu, Gary Tse, Jiandong Zhou, Kang-Yin Chen, Gregory Y. H. Lip and Tong Liu
    Citation: BMC Medicine 2025 23:557
  2. Recent international guidelines emphasize a multidisciplinary, patient-centered approach to managing atrial fibrillation (AF), particularly regarding antithrombotic (antiplatelet and anticoagulant) management....

    Authors: Maïwenn Prunel, Alexis Cochard, Leila Abbas, Elodie Baudry, Eric Pautas, Nicolas Legris, Patrick Assayag, Corinne Frere, Marc Verny, Noémie Simon-Tillaux and Lorene Zerah
    Citation: BMC Medicine 2025 23:521
  3. Remnant cholesterol (RC) has been implicated in cardiovascular diseases (CVDs) in populations of European ancestry, yet its causal role remains underexplored in populations of East Asian ancestry, which are un...

    Authors: Chenhao Lin, Haolong Wen, Mengyao Yu, Qingxia Huang, Qi Wang, Jinran Lin, Wenjun Yang, Jennifer Ming Jen Wong, Mingfeng Xia, Huiru Tang, Li Jin, Sijia Wang, Xiaofeng Wang, Yuxiang Dai, Guo-Chong Chen and Yan Zheng
    Citation: BMC Medicine 2025 23:495
  4. Emerging epidemiological evidence implicates pulmonary dysfunction in cardiovascular pathogenesis, yet its arrhythmogenic potential remains poorly defined.

    Authors: Yun-Jiu Cheng, Li-Ping Qu, Yi-Jian Liao, Si-Long Lu, Mei-Ping Lin, Qian He, Jin-Bo Fu, Jun-Chi Li, Wen-Juan Duan and Li-Juan Liu
    Citation: BMC Medicine 2025 23:493
  5. Chronic inflammatory cardiomyopathy (infl-CMP) is a long-term sequela caused by the chronicity of acute myocarditis, especially fulminant myocarditis (FM). Hydroxychloroquine (HCQ) may benefit these patients b...

    Authors: Wu He, Guanglin Cui, Juan Chen, Manhua Chen, Rui Li, Luyun Wang, Ting Yu, Gen Li, Jiangang Jiang and Dao Wen Wang
    Citation: BMC Medicine 2025 23:467
  6. Patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) exhibit structural and functional cardiac abnormalities. We aimed to identify imaging biomarkers for pre-clinical cardiomyopathy...

    Authors: Philip M. Croon, Marion van Vugt, Cornelis P. Allaart, Bram Ruijsink, Perry M. Elliott, Folkert W. Asselbergs, Rohan Khera, Connie R. Bezzina, Michiel Winter and A. Floriaan Schmidt
    Citation: BMC Medicine 2025 23:421
  7. Left ventricular (LV) trabeculation are increasingly observed in patients with hypertrophic cardiomyopathy (HCM), but its clinical significance remains controversial. This study aims to clarify the characteris...

    Authors: Yu Zhang, Di Zhou, Yuming Zhu, Qiya Huang, Jizheng Wang, Channa Zhang, Lianming Kang, Minjie Lu and Lei Song
    Citation: BMC Medicine 2025 23:318
  8. Fibro-fatty replacement of the myocardium plays a key role in the pathogenesis of arrhythmogenic cardiomyopathy (ACM) and may be associated with progressive heart failure (HF). We aimed to investigate the char...

    Authors: Hao Cui, Songren Shu, Ningning Zhang, Mangyuan Wang, Tianshuo Yang, Zhen Wang, Xiao Chen, Mengxia Fu, Mengda Xu, Yicheng Yang, Peizhi Wang, Chuangshi Wang, Qiaoxi Yang, Huimin Gao, Yao Jiang and Jiangping Song
    Citation: BMC Medicine 2025 23:213

Submission Guidelines

Back to top

BMC Medicine encourages submissions of front matter articles and original research, including clinical trials (phase I-III, randomized-controlled, either positive or negative trials), epidemiological studies (retrospective or prospective), systematic reviews and meta-analyses, -omics, medical imaging, genomics studies and translational research. Before submitting your manuscript, please ensure you have read our submission guidelines.

Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection; please select "Cardiomyopathy and cardiac arrhythmias" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.